About Endovascular Engineering
Endovascular Engineering develops and deploys advanced clot removal solutions for the treatment of venous thromboembolism.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B
Global Headquarters
Menlo Park, United States
Year Founded
2019
Team Size
11–50 employees
Tracked Since
Nov 8, 2026
Web & Domain Identity
Official Website
endovascularengineering.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
@SavastanoLuisMD
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $80,000,000 · Series-B
Backed by Gilde Healthcare
- Capital Raise
Raised $42,000,000 · Series-B
Backed by 415 Capital
- Capital Raise
Raised $15,000,000 · Series-A
Backed by Cordis
- Milestone
Company founded
Menlo Park, United States
Investors & Backers
415 Capital
Lead
Cordis
Lead
Gilde Healthcare
Lead
M&L Healthcare Investments
Norwest Venture Partners
Panakes Partners
S3 Ventures
Sante Ventures
Funding History
Series-B equity
· Apr 7, 2026
Round backers: Gilde Healthcare
$80,000,000 finsmes.com
Series-B equity
· Mar 9, 2025
Round backers: 415 Capital
$42,000,000 startupintros.com
Series-A equity
· Apr 6, 2022
Round backers: Cordis
$15,000,000 startupintros.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026